Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Prazosin hydrochloride
Cat. No.:
OB0225LY-0449
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Prazosin hydrochloride is an α1-adrenergic antagonist mainly used to lower blood pressure.
Synonym:
Prazosin HCl; Peripress; Vasoflex; Minipress; 19237-84-4; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine hydrochloride; (4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(furan-2-yl)methanone hydrochloride; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)piperazine monohydrochloride
CAS No.:
19237-84-4
Compound CID:
68546
Formula:
C19H22ClN5O4
Formula Weight:
419.86
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Prazosin hydrochloride can be used in cardiovascular biology research to explore the role of adrenaline in blood pressure regulation.
Library Information
Targets:
G protein-coupled receptors (GPCRs); Monoamine transporters
Receptors:
ABCG; Adrenergic receptor; MRP1; Potassium channel
Pathways:
Autophagy; Immunology/Inflammation; Neuronal signaling; Membrane transporter/Ion channel; GPCR/G protein
Plate Number:
AOCL-6
Plate Location:
g6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
55 mg/mL; 131 mM
Ethanol Max Solubility:
5 mM
